A Fourth IκB Protein within the NF-κB Signaling Module

Cell

Volumn 128, Issue 2, 2007, Pages 369-381

  Basak, Soumen ^a   Kim, Hana ^a   Kearns, Jeffrey D ^a   Tergaonkar, Vinay ^b   O'Dea, Ellen ^a   Werner, Shannon L ^a   Benedict, Chris A ^c   Ware, Carl F ^c   Ghosh, Gourisankar ^a   Verma, Inder M ^b   Hoffmann, Alexander ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; I KAPPA B KINASE; I KAPPA B KINASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN INDUCING KINASE; PROTEIN P100; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; CHUK PROTEIN, HUMAN; NF KAPPA B KINASE; NF-KAPPA B KINASE; NFKB2 PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ARTICLE; CELL MUTANT; CELL STRAIN 3T3; COMPLEX FORMATION; EMBRYO; GENE EXPRESSION; INFLAMMATION; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; BINDING SITE; BIOLOGY; CELL LINE; COMPUTER SIMULATION; GENE EXPRESSION REGULATION; GENETICS; MACROMOLECULE; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT;

ANIMALS; BINDING SITES; CELL LINE, TRANSFORMED; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; GENE EXPRESSION REGULATION; I-KAPPA B KINASE; I-KAPPA B PROTEINS; INFLAMMATION; MACROMOLECULAR SUBSTANCES; MICE; MICE, KNOCKOUT; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; NF-KAPPA B P52 SUBUNIT; NIH 3T3 CELLS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 33846323310     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2006.12.033     Document Type: Article

References (40)

1. Alcamo E., Hacohen N., Schulte L.C., Rennert P.D., Hynes R.O., and Baltimore D. Requirement for the NF-kappaB family member RelA in the development of secondary lymphoid organs. J. Exp. Med. 195 (2002) 233-244
2. Baeuerle P.A., and Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242 (1988) 540-546
3. Beinke S., and Ley S.C. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem. J. 382 (2004) 393-409
4. Bonizzi G., Bebien M., Otero D.C., Johnson-Vroom K.E., Cao Y., Vu D., Jegga A.G., Aronow B.J., Ghosh G., Rickert R.C., and Karin M. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J. 23 (2004) 4202-4210
5. Browning J.L., Allaire N., Ngam-Ek A., Notidis E., Hunt J., Perrin S., and Fava R.A. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity 23 (2005) 539-550
6. Dejardin E., Droin N.M., Delhase M., Haas E., Cao Y., Makris C., Li Z.W., Karin M., Ware C.F., and Green D.R. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17 (2002) 525-535
7. Derudder E., Dejardin E., Pritchard L.L., Green D.R., Korner M., and Baud V. RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. J. Biol. Chem. 278 (2003) 23278-23284
8. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl (2002) S81-S96
9. Hatada E.N., Nieters A., Wulczyn F.G., Naumann M., Meyer R., Nucifora G., McKeithan T.W., and Scheidereit C. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. Proc. Natl. Acad. Sci. USA 89 (1992) 2489-2493
10. Hoffmann A., and Baltimore D. Circuitry of nuclear factor kappaB signaling. Immunol. Rev. 210 (2006) 171-186
11. Hoffmann A., Levchenko A., Scott M.L., and Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298 (2002) 1241-1245
12. Hoffmann A., Leung T.H., and Baltimore D. Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J. 22 (2003) 5530-5539
13. Inoue J., Kerr L.D., Kakizuka A., and Verma I.M. I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family. Cell 68 (1992) 1109-1120
14. Ishimaru N., Kishimoto H., Hayashi Y., and Sprent J. Regulation of naive T cell function by the NF-kappaB2 pathway. Nat. Immunol. 7 (2006) 763-772
15. Jiang X., Takahashi N., Matsui N., Tetsuka T., and Okamoto T. The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. J. Biol. Chem. 278 (2003) 919-926
16. Karin M., Yamamoto Y., and Wang Q.M. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3 (2004) 17-26
17. Katakai T., Hara T., Sugai M., Gonda H., and Shimizu A. Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J. Exp. Med. 200 (2004) 783-795
18. Kearns J.D., Basak S., Werner S.L., Huang C.S., and Hoffmann A. I kappa B epsilon provides negative feedback to control NF-kappa B oscillations, signaling dynamics, and inflammatory gene expression. J. Cell Biol. 173 (2006) 659-664
19. Knuesel M., Wan Y., Xiao Z., Holinger E., Lowe N., Wang W., and Liu X. Identification of novel protein-protein interactions using a versatile Mammalian tandem affinity purification expression system. Mol. Cell. Proteomics 2 (2003) 1225-1233
20. Krappmann D., Emmerich F., Kordes U., Scharschmidt E., Dorken B., and Scheidereit C. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene 18 (1999) 943-953
21. Lo J.C., Basak S., James E.S., Quiambo R.S., Kinsella M.C., Alegre M.L., Weih F., Franzoso G., Hoffmann A., and Fu Y.X. Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues. Blood 107 (2006) 1048-1055
22. Mebius R.E. Organogenesis of lymphoid tissues. Nat. Rev. Immunol. 3 (2003) 292-303
23. Mercurio F., DiDonato J.A., Rosette C., and Karin M. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction. Genes Dev. 7 (1993) 705-718
24. Moorthy A.K., and Ghosh G. p105.Ikappa Bgamma and prototypical Ikappa Bs use a similar mechanism to bind but a different mechanism to regulate the subcellular localization of NF-kappa B. J. Biol. Chem. 278 (2003) 556-566
25. Moorthy A.K., Savinova O.V., Ho J.Q., Wang V.Y., Vu D., and Ghosh G. The 20S proteasome processes NF-kappaB1 p105 into p50 in a translation-independent manner. EMBO J. 25 (2006) 1945-1956
26. Mordmuller B., Krappmann D., Esen M., Wegener E., and Scheidereit C. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism. EMBO Rep. 4 (2003) 82-87
27. Muller J.R., and Siebenlist U. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. J. Biol. Chem. 278 (2003) 12006-12012
28. Naumann M., Nieters A., Hatada E.N., and Scheidereit C. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/Rel-factors. Oncogene 8 (1993) 2275-2281
29. Ramakrishnan P., Wang W., and Wallach D. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase. Immunity 21 (2004) 477-489
30. Rennert P.D., James D., Mackay F., Browning J.L., and Hochman P.S. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity 9 (1998) 71-79
31. Schneider K., Potter K.G., and Ware C.F. Lymphotoxin and LIGHT signaling pathways and target genes. Immunol. Rev. 202 (2004) 49-66
32. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., Chen Y., Hu Y., Fong A., Sun S.C., and Karin M. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293 (2001) 1495-1499
33. Shinkura R., Kitada K., Matsuda F., Tashiro K., Ikuta K., Suzuki M., Kogishi K., Serikawa T., and Honjo T. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa B-inducing kinase. Nat. Genet. 22 (1999) 74-77
34. Tergaonkar V., Correa R.G., Ikawa M., and Verma I.M. Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. Nat. Cell Biol. 7 (2005) 921-923
35. Weih D.S., Yilmaz Z.B., and Weih F. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. Immunol. 167 (2001) 1909-1919
36. Weih F., and Caamano J. Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway. Immunol. Rev. 195 (2003) 91-105
37. Werner S.L., Barken D., and Hoffmann A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309 (2005) 1857-1861
38. Xiao G., Harhaj E.W., and Sun S.C. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol. Cell 7 (2001) 401-409
39. Yamamoto M., Yamazaki S., Uematsu S., Sato S., Hemmi H., Hoshino K., Kaisho T., Kuwata H., Takeuchi O., Takeshige K., et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 430 (2004) 218-222
40. Zarnegar B., He J.Q., Oganesyan G., Hoffmann A., Baltimore D., and Cheng G. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kappaB activation pathways. Proc. Natl. Acad. Sci. USA 101 (2004) 8108-8113